In vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii and Stenotrophomonas maltophilia

被引：42

作者：

Insa, R. ^{[1
]}

Cercenado, E. ^{[1
]}

Goyanes, M. J. ^{[1
]}

Morente, A. ^{[1
]}

Bouza, E. ^{[1
]}

机构：

[1] Univ Complutense Madrid, Hosp Gen, Serv Microbiol & Enfermedades Infecc, Madrid, Spain

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2007年 / 59卷 / 03期

关键词：

A; baumannii; S; maltophilia; glycylcyclines;

D O I：

10.1093/jac/dkl496

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：583 / 585

页数：3

共 6 条

[1]

*CLIN LAB STAND I, 2006, M100S16 NCCLS S

[2] Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936) [J].

Henwood, CJ ;

Gatward, T ;

Warner, M ;

James, D ;

Stockdale, MW ;

Spence, RP ;

Towner, KJ ;

Livermore, DM ;

Woodford, N .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (03) :479-487

[3] Effects of efflux transporter genes on susceptibility of Escheichia coli to tigecycline (GAR-936) [J].

Hirata, T ;

Saito, A ;

Nishino, K ;

Tamura, N ;

Yamaguchi, A .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (06) :2179-2184

[4] Tigecycline: what is it, and where should it be used? [J].

Livermore, DM .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (04) :611-614

[5] Activity of tigecycline (GAR-936) against Acinetobacter baumannii strains, including those resistant to imipenem [J].

Pachón-Ibáñez, ME ;

Jiménez-Mejías, ME ;

Pichardo, C ;

Llanos, AC ;

Pachón, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (11) :4479-4481

[6] Mutations in the interdomain loop region of the tetA(A) tetracycline resistance gene increase efflux of minocycline and glycylcyclines [J].

Tuckman, M ;

Petersen, PJ ;

Projan, SJ .

MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 2000, 6 (04) :277-282

← 1 →